Clinical Trials Directory

Trials / Completed

CompletedNCT01071473

Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
St. Jude Children's Research Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This application proposes a prospective, single arm feasibility clinical trial of a 12-week period of combined endurance and resistance training in survivors of childhood cancer who were treated with doxorubicin and/or daunorubicin and have impaired cardiac function. Baseline and post intervention imaging, laboratory, and neuropsychological evaluations will be used to determine the effects of the intervention on body composition, serum lipid profile, exercise tolerance, and neurocognitive functioning. Participants will be called weekly to monitor compliance with the intervention. Incentives will be given at intervals during the trial to optimize compliance with the intervention.

Detailed description

This study will evaluate the feasibility of a 12-week exercise intervention on the cardiac function of survivors of childhood cancer treated with anthracyclines and known to have cardiomyopathy. As a secondary objective, the study will document the effect of a 12-week exercise intervention on exercise tolerance, as determined by measurement of peak VO2 and peak exercise workload, shortening fraction, ejection fraction, and left ventricular wall thickness, and assess the impact of the intervention on neurocognitive functioning in survivors of childhood cancer treated with anthracyclines and known to have cardiomyopathy.

Conditions

Interventions

TypeNameDescription
OTHER12 Week Exercise InterventionTrial of a 12-week period of combined endurance and resistance training in survivors of childhood cancer who were treated with doxorubicin and/or daunorubicin and have impaired cardiac function.

Timeline

Start date
2010-02-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2010-02-19
Last updated
2014-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01071473. Inclusion in this directory is not an endorsement.